Clinical Trial Update: Everolimus and/or Exercise to Prevent Bone Loss in Postmenopausal Women [Phase 2]

View source ↗

Summary

Phase 2 clinical trial evaluating everolimus and/or exercise to prevent bone loss in postmenopausal women; currently active but not recruiting.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Postmenopausal Osteoporosis

Drugs mentioned

• Everolimus (everolimus)

Snippet

Sponsor: Odense University Hospital | Conditions: Postmenopausal Women | Phase 2 | Status: ACTIVE_NOT_RECRUITING